We are live on ! Find out more
MLAB icon

Mesa Laboratories

178 hedge funds and large institutions have $1.57B invested in Mesa Laboratories in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 69 increasing their positions, 52 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 17

33% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 52

9% more capital invested

Capital invested by funds: $1.44B → $1.57B (+$129M)

3% more funds holding

Funds holding: 172178 (+6)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.04% less ownership

Funds ownership: 91.66%91.62% (-0.04%)

Holders
178
Holders Change
+6
Holders Change %
+3.49%
% of All Funds
2.73%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
24
Increased
69
Reduced
52
Closed
17
Calls
Puts
Net Calls
Net Calls Change

MLAB Hedge Fund Activity: Q4 2021 in Review

178 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2021, worth a combined $1.57B — up 9% from $1.44B a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new MLAB positions and 17 closed out — a net gain of 7 holders — while 69 added to existing stakes and 52 trimmed.

The largest buyer was BlackRock, adding an estimated $11.6M. The largest seller was T. Rowe Price Associates, cutting an estimated $35M.

  • 178 institutional investors held Mesa Laboratories (MLAB) as of Q4 2021, up from 172 in Q3 2021.
  • Funds reported $1.57B of Mesa Laboratories stock for Q4 2021, up 9% quarter-over-quarter.
  • 24 funds opened new Mesa Laboratories positions in Q4 2021 and 17 closed out, a net change of +7 holders.
  • The largest Mesa Laboratories buyer in Q4 2021 was BlackRock, an estimated $11.6M added.
  • The largest Mesa Laboratories seller in Q4 2021 was T. Rowe Price Associates, an estimated $35M sold.

Based on aggregated 13F filings for Q4 2021.